1. Evidence-Based Medicine
! " # $" ! %# &
'(!) # *% ! * *+ , # - " . / 0 ! #
* * '(!)/ .( ! 12 ) )
Evidence-Based Medicine $ 12 #$ ! ) 0
?/ @ 0 " Evidence-Based / /1 / 0 12 Nursing
% Pharmacy % Dentistry % Public Health
Evidence-Based Medicine % N / ) ) 1 0 N # 12 N * #
!) O )" # )%# .% / 1 0 ! @ * 0 + N '(1P
" ! Q N * " * ) # .)"! ? !
! %# N " @ 0 # ) ) 1 0 N/ *1 0
# 12 N * # ' ' 3 *1 0 *%
1. )" # )%# .% / # N * " U
2. * )# ) W! N *
3. * % '1P !
( N *
*1 0 3 # * /1 # *1 0 #1
EBM !"
%# ' & QX 0 ) ? ! / .( +
/1 021 0 ?
1. %# EBM 12 1Y N '(1P # !) O N ?0 O
" / # *% # 10 Q *% 0 *
% # # # % # # 12 1 0 ) 0 # "
0 /1 ! ( ( * '(!) ! ) 0 %# %# ! N
* 1 0 Q' EBM
2. %# EBM * ! O %# N ? * !
* " ! / # *% 0 * 0
. *% %# U / ? .( 0 + # " 0 #% #0

2. +! / 0 .1 0 / * $ !! ! ! 0 /
( 85 1 ?
?* 0 +! /
# $! %& Collection +$,- EBM
! 0 Collection # *_ 12 .%
12 # ! ! 0 / *_ ? 0
*_ ) 1Y " 0 12 )" * 0 0/ $ 0 +!
'(!) ` ! #'(!) ! # # 0 + / EBM 12 +
0 %# EBM / / $# 0/
1. 0 #* *_ # N * U
.$ )" (Best research) % O #% U # )%# .% / )
# N * #/ * 0 12 0 % # Systematic review
2. 0 ( # # / 0 1 %
Website 0O ( U Cochrane Library 0 UpToDate *%
Q *_0 0 %# # ! #
10 Q ) % 0* %! ! 0
./." + %& 0 0 !# .& #1- .0 #
0 0 N * EBM 0 *_*
0 O * *_* /1 "
1. N-of-1 Randomized Control Trial (RCT) 12 O #/ 1
N #$ ) ! '(1P #$ * .% 12 O # # 0*+ #/ 12 *+ #/
'(1P # 1 N " U " O #/ $ 12 O @ 0
2. Mata-Analysis 12 O #/ * 0 12 + %# #
*+ . * #% 1 0 ) ! _ #' ! U/ % )
N/ ' N/ / ' * 0 + U " 0 +
! ? 1) $" $# * * 0 N )%# .% /
3. Single RCT 12 O #/ ! '(1P * ! # #
0 +/
4. $N _
5. $N ! %!
6. 1 0 _ *

3. % 0. 2 3".0 +45 +&6
! # 12 " ( % 0 12 %# # pY * ( * 12 # "
0 12 ! / " Q 0 1Q '(!
( 0'(!) . /
% / 0* 0 1 1 ! %# !
*1 0 * 12 " 3 *1 0 *% * 0*
O ! ! # 12
- . .% 12 *1 0 # + *W # # 0 12 / % /
1Y " ( .$ . 0 . 0 0 12 *_ * / . ' & QX
! 12 * 0 . 0 / $ 0.$ _q * 12 $# 0
# ( 0 (* 12 * # (0 + 0/ + / 0 ` 0/
! Q .% 12 1Y # + *W # % '( # *_ # # $10 * % ` *
# ( # ! 0 + / # /
- * (* ! N_0 EBM 12
- * .! ! / 10 Q * .( ? 0
+
- * 0 0
- .0 + * #% /
- 0 # U
- # $! %# ( .$ * 12 ` 0
%# ! * * '!)( " 0 ( .$ *
0 * ? 12 / / # *% 0
( .$ (21 0 ? U *% # *_* * '(!) 0
. '(!)/
- 1 78 2 #1-+45 +&6 *+ O ! ! # 12 " .% 12
Q U ? . (/ 0/ 0/ / # # '(!)* " 0.% 12
O # 0 ? / 0 + /1 %" O * $ ! '(!) 0
** ( 0!) Q ** ! #% ( O ! # 12 ?
/ / $ 0 * * '(!) # .% 12 '(!) ?
12 ! !) '(! ? * #/ * ! '(!) * $#
0 O ! #% /1 "

4. 1. * * * ! ! ( # + $! ! #0
* (* .! * ( '(!) 10 Q * $
!/ )" **
2. 0 ' Q! ! #) ! EBM
) $ ) r r ' Q # " * 0 12 ! / *% , 12
( 0 12 ? )" + 1 0 - # *% 0 ` ! # /1 "
- ! 12 ( # ) ) # *_
0
- ! 12 ? 0 `
#%
- ` ! '(!) . .$ One-stop access of
formation ! (! 0 1 ! 5 1 0 12
9:- #; 1;
.& &" < $# . ..... ., >3
+ ., % !" #1 .?
+ + @"0! + +$- $&
2 0 A#BC+&6 4 + 8